Aerie Pharmaceuticals, Inc. (AERI)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in Aerie Pharmaceuticals, Inc. in Jun 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $14,373 for a total return of roughly 43.73%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
Aerie Pharmaceuticals, Inc. had a return of 117.24% year-to-date (YTD) and 40.04% in the last 12 months. Over the past 10 years, Aerie Pharmaceuticals, Inc. had an annualized return of 4.09%, while the S&P 500 had an annualized return of 9.38%, indicating that Aerie Pharmaceuticals, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 0.46% | 6.60% |
| 6 months | 113.59% | 1.65% |
| Year-To-Date | 117.24% | -16.80% |
| 1 year | 40.04% | -15.43% |
| 5 years (annualized) | -23.65% | 8.99% |
| 10 years (annualized) | 4.09% | 9.38% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -27.14% | 44.79% | -6.53% | 115.41% | 0.20% | 0.59% |
Dividend History
Aerie Pharmaceuticals, Inc. doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Aerie Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Aerie Pharmaceuticals, Inc. is 93.30%, recorded on Jun 1, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.3% | Jul 20, 2018 | 974 | Jun 1, 2022 | — | — | — |
| -73.52% | Apr 24, 2015 | 6 | May 1, 2015 | 350 | Sep 20, 2016 | 356 |
| -44.78% | Mar 5, 2014 | 46 | May 8, 2014 | 33 | Jun 25, 2014 | 79 |
| -39.55% | Jun 27, 2014 | 29 | Aug 7, 2014 | 77 | Nov 25, 2014 | 106 |
| -26.56% | Jan 16, 2014 | 8 | Jan 28, 2014 | 21 | Feb 27, 2014 | 29 |
| -26.5% | Oct 23, 2017 | 138 | May 10, 2018 | 19 | Jun 7, 2018 | 157 |
| -23.32% | Mar 8, 2017 | 50 | May 17, 2017 | 6 | May 25, 2017 | 56 |
| -21.5% | Jan 5, 2015 | 23 | Feb 5, 2015 | 30 | Mar 20, 2015 | 53 |
| -19.82% | Oct 11, 2016 | 19 | Nov 4, 2016 | 7 | Nov 15, 2016 | 26 |
| -19.13% | Sep 19, 2017 | 9 | Sep 29, 2017 | 8 | Oct 11, 2017 | 17 |
Volatility Chart
Current Aerie Pharmaceuticals, Inc. volatility is 0.90%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.